Ankasa Regenerative Therapeutics
Ankasa Therapeutics: Advancing regenerative medicine through stem cell technology for improved tissue healing.
Founded
2014Ankasa Therapeutics: Advancing regenerative medicine through stem cell technology for improved tissue healing.
Ankasa Regenerative Therapeutics, founded with a mission to advance regenerative medicine, focuses on developing novel protein-based therapies to enhance tissue repair and regeneration. The company's core technology revolves around the WNT stem cell activator, which aims to accelerate healing in tissues such as bone, cartilage, skin, muscle, vasculature, and the central nervous system. Ankasa's vision is to harness the power of stem cell reactivation to address various degenerative conditions and improve patient outcomes.
Notable figures associated with Ankasa include experienced professionals in biopharmaceuticals and regenerative medicine. The company has garnered attention from key investors in the biotech sector, underscoring its potential impact. Ankasa's significant achievements include the development of proprietary formulations that have shown promise in preclinical studies. By pushing the boundaries of stem cell technology, Ankasa Regenerative Therapeutics is poised to make substantial contributions to the field of tissue regeneration and overall healthcare innovation.
Companies similar to Ankasa Regenerative Therapeutics include APstem Therapeutics, Stemgenics, Aspen Neuroscience and Stemedica Cell Technologies.
Ankasa Regenerative Therapeutics was founded in 2014.
Ankasa Regenerative Therapeutics' headquarters is located in Los Angeles, CA, US.
Ankasa Regenerative Therapeutics' most recent funding round was for $6M (USD) in October 2020.
As of Oct 13, 2020, Ankasa Regenerative Therapeutics has raised a total of $14.5M (USD).
Ankasa Regenerative Therapeutics has 3,000 employees as of Feb 5, 2024.
Aspen Neuroscience
